The authors Min-Jean Yin and Rounak Nassirpour and a Pfizer representative contacted the editorial office to raise that there are image duplications in Figure 4B of this article. Pfizer has undertaken a review and deemed that important conclusions in the manuscript cannot be verified, as original images cannot be located.
In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any response or comment from Pramod Mehta.
Reference
Citation: The PLOS ONE Editors (2017) Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells. PLoS ONE 12(4): e0175869. https://doi.org/10.1371/journal.pone.0175869
Published: April 10, 2017
Copyright: © 2017 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.